Diabetes & metabolic syndrome · 2025
The effectiveness of telemedicine in the prevention of type 2 diabetes mellitus: a systematic review and meta-analysis of interventions.
СтатьяМетаанализСистематический обзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Suhlrie Laura, Ayyagari Raga, Mba Camille, Olsson Kjell, Torres-Aparcana Harold, James Steven, Vounzoulaki Elpida, Ibsen Daniel B
Аннотация
OBJECTIVE: To evaluate the effectiveness of telemedicine-delivered diet and/or exercise interventions to prevent type 2 diabetes (T2D) in people at risk.
METHODS: Embase (via Ovid), Medline (via Ovid), Web of Science, CINAHL, Scopus and SciELO were searched from January 2010-December 2020 for intervention studies using a diet and/or exercise intervention delivered through telemedicine for T2D prevention in people at risk. Parallel randomised controlled trials were meta-analysed, and other intervention designs narratively synthesized.
RESULTS: We identified 11,645 studies via database searches, of which 226 were full-text screened, and 52 interventions included; 32 were included in the meta-analysis and 20 in the narrative synthesis. Telemedicine interventions reduced body weight (mean difference (MD): -1.66 kg, 95 % confidence interval (CI) -2.48,-0.90, I2 = 81 %, nstudies = 17), body mass index (MD -0.71 kg/m2, 95 % CI -1.06,-0.37, I2 = 70 %, nstudies = 11), waist circumference (MD -2.82 cm, 95 % CI -5.16,-2.35, I2 = 84 %, nstudies = 8) and HbA1c (MD -0.07 %, 95 % CI -0.14,0.00, I2 = 71 %, nstudies = 11). No significant effects were found for other clinical outcomes. The narrative synthesis supported the results. The longest follow-up time was up to 24 months.
CONCLUSIONS: Our study demonstrates effectiveness for telemedicine-delivered interventions in preventing T2D in people at risk, specifically in people with overweight/obesity.
METHODS: Embase (via Ovid), Medline (via Ovid), Web of Science, CINAHL, Scopus and SciELO were searched from January 2010-December 2020 for intervention studies using a diet and/or exercise intervention delivered through telemedicine for T2D prevention in people at risk. Parallel randomised controlled trials were meta-analysed, and other intervention designs narratively synthesized.
RESULTS: We identified 11,645 studies via database searches, of which 226 were full-text screened, and 52 interventions included; 32 were included in the meta-analysis and 20 in the narrative synthesis. Telemedicine interventions reduced body weight (mean difference (MD): -1.66 kg, 95 % confidence interval (CI) -2.48,-0.90, I2 = 81 %, nstudies = 17), body mass index (MD -0.71 kg/m2, 95 % CI -1.06,-0.37, I2 = 70 %, nstudies = 11), waist circumference (MD -2.82 cm, 95 % CI -5.16,-2.35, I2 = 84 %, nstudies = 8) and HbA1c (MD -0.07 %, 95 % CI -0.14,0.00, I2 = 71 %, nstudies = 11). No significant effects were found for other clinical outcomes. The narrative synthesis supported the results. The longest follow-up time was up to 24 months.
CONCLUSIONS: Our study demonstrates effectiveness for telemedicine-delivered interventions in preventing T2D in people at risk, specifically in people with overweight/obesity.